[
  {
    "ts": "2025-07-10T16:09:00+00:00",
    "headline": "Reasons to Add Fresenius Medical Stock to Your Portfolio Now",
    "summary": "FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.",
    "url": "https://finance.yahoo.com/news/reasons-add-fresenius-medical-stock-160900743.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "5b2a3c41-7902-3e9f-b443-00dbbe1b273f",
      "content": {
        "id": "5b2a3c41-7902-3e9f-b443-00dbbe1b273f",
        "contentType": "STORY",
        "title": "Reasons to Add Fresenius Medical Stock to Your Portfolio Now",
        "description": "",
        "summary": "FMS continues to gain traction on the back of acquisitions & partnerships. A tough regulatory environment raises concerns.",
        "pubDate": "2025-07-10T16:09:00Z",
        "displayTime": "2025-07-10T16:09:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rR6iZHXu8FRY2qc4ebuBNA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TXlDKOevAW4cJAnlMECSwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/3ecb7b8f4826ee26a884371aa5efe958.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/reasons-add-fresenius-medical-stock-160900743.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/reasons-add-fresenius-medical-stock-160900743.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COR"
            },
            {
              "symbol": "FMCQF"
            },
            {
              "symbol": "FMS"
            },
            {
              "symbol": "ITGR"
            },
            {
              "symbol": "HIMS"
            },
            {
              "symbol": "FME.DE"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-10T12:21:00+00:00",
    "headline": "ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise?",
    "summary": "Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.",
    "url": "https://finance.yahoo.com/news/abts-freestyle-libre-3-plus-122100355.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "f4cf8793-2c58-3092-a20e-2495b9e9a444",
      "content": {
        "id": "f4cf8793-2c58-3092-a20e-2495b9e9a444",
        "contentType": "STORY",
        "title": "ABT's FreeStyle Libre 3 Plus Now Available in Canada: Stock to Rise?",
        "description": "",
        "summary": "Abbott debuts FreeStyle Libre 3 Plus in Canada, enhancing diabetes care with the world's smallest glucose sensor.",
        "pubDate": "2025-07-10T12:21:00Z",
        "displayTime": "2025-07-10T12:21:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9f7296fade0c729cbae8baf4df367222",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vAG7Ez9jb7JTt_ns5ykz0A--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f7296fade0c729cbae8baf4df367222.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/vwUeqqre14obWSY83ppBxA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9f7296fade0c729cbae8baf4df367222.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abts-freestyle-libre-3-plus-122100355.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abts-freestyle-libre-3-plus-122100355.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BSX"
            },
            {
              "symbol": "COR"
            },
            {
              "symbol": "ABT"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-10T12:19:00+00:00",
    "headline": "Here's Why You Should Retain CONMED Stock in Your Portfolio for Now",
    "summary": "CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.",
    "url": "https://finance.yahoo.com/news/heres-why-retain-conmed-stock-121900138.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3c9e7f50-baad-3f5e-887a-37b7f92c08e2",
      "content": {
        "id": "3c9e7f50-baad-3f5e-887a-37b7f92c08e2",
        "contentType": "STORY",
        "title": "Here's Why You Should Retain CONMED Stock in Your Portfolio for Now",
        "description": "",
        "summary": "CNMD stock rides high on strong recurring revenues, margin gains, and surgical product growth despite supply and cybersecurity challenges.",
        "pubDate": "2025-07-10T12:19:00Z",
        "displayTime": "2025-07-10T12:19:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/uKAK5RzbQ_vsUIbORK8gvQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0coGOoYQ8rONNrj5AqJ8kw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/529a2bf6a4c772f942409efa3808349b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-conmed-stock-121900138.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/heres-why-retain-conmed-stock-121900138.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            },
            {
              "symbol": "COR"
            },
            {
              "symbol": "CNMD"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-10T12:19:00+00:00",
    "headline": "Should You Continue to Hold STERIS Stock in Your Portfolio Now?",
    "summary": "STE rides on strong Healthcare and AST growth, but macro pressures and customer consolidation cloud its outlook.",
    "url": "https://finance.yahoo.com/news/continue-hold-steris-stock-portfolio-121900551.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "daebb64b-82b1-3079-876a-7be7cb37b7c4",
      "content": {
        "id": "daebb64b-82b1-3079-876a-7be7cb37b7c4",
        "contentType": "STORY",
        "title": "Should You Continue to Hold STERIS Stock in Your Portfolio Now?",
        "description": "",
        "summary": "STE rides on strong Healthcare and AST growth, but macro pressures and customer consolidation cloud its outlook.",
        "pubDate": "2025-07-10T12:19:00Z",
        "displayTime": "2025-07-10T12:19:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TNBAnrhWOnvvvNSvMEIuFg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/rP7ZEHNft_Sb_FB9M.3i3w--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/9c1d11cd27737fac4805145de6e5eee0.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/continue-hold-steris-stock-portfolio-121900551.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/continue-hold-steris-stock-portfolio-121900551.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            },
            {
              "symbol": "COR"
            },
            {
              "symbol": "STE"
            },
            {
              "symbol": "STE"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-07-10T12:18:00+00:00",
    "headline": "Is it Worth Adding Boston Scientific Stock to Your Portfolio Now?",
    "summary": "BSX rides on strong MedSurg growth and strategic acquisitions amid currency headwinds.",
    "url": "https://finance.yahoo.com/news/worth-adding-boston-scientific-stock-121800922.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "b4eabb93-ffe3-38e5-ac09-0e71ee6cb2fc",
      "content": {
        "id": "b4eabb93-ffe3-38e5-ac09-0e71ee6cb2fc",
        "contentType": "STORY",
        "title": "Is it Worth Adding Boston Scientific Stock to Your Portfolio Now?",
        "description": "",
        "summary": "BSX rides on strong MedSurg growth and strategic acquisitions amid currency headwinds.",
        "pubDate": "2025-07-10T12:18:00Z",
        "displayTime": "2025-07-10T12:18:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/.Z6CaNjdpI8OLeo5.Ul_eA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/o6kyOwY40meLORq99yf8XA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/5d5a6eb884ce28277f39a4369974b5ea.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/worth-adding-boston-scientific-stock-121800922.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/worth-adding-boston-scientific-stock-121800922.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "COR"
            },
            {
              "symbol": "ABT"
            },
            {
              "symbol": "BSX"
            },
            {
              "symbol": "^SPX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]